Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1992;1(4):251–254. doi: 10.1155/S0962935192000383

Selective inhibition by antiflamrnin-2 of thromboxane B2 release from isolated and perfused guinea-pig lung

Lidia Sautebin 1,✉, Giuseppe Cirino 1, Massimo Di Rosa 1
PMCID: PMC2365348  PMID: 18475469

Abstract

Antiflammin-2 (AF2) is a nonapeptide corresponding to the amino acid residues 246–254 of lipocortin-1 showing anti-inflammatory activity both in vitro and in vivo. The effect of AF2 on the thromboxane B2 (TXB2) and histamine release from isolated and perfused guinea-pig lungs has been studied. AF-2 (10–100 nM) inhibited leukotriene C4- (LTC4) (3 ng) and antigen-induced (ovalbumin, 1 mg) TXB2 release in normal and sensitized lungs, respectively. In contrast AF-2 (100 nM) did not modify TXB2 release induced by histamine (5 μg) or bradykinin (5 μg) in normal lungs. Antigen-induced histamine release was not affected by 100 nM AF-2 infusion. When tested in chopped lung fragments AF-2 (0.1–25 μM) did not modify the release of histamine and TXB2 induced by antigen (ovalbumin, 10 μg ml−1) or calcium ionophore A 23187 (1 μM). Our results show that the inhibitory effect of AF-2 on TXB2 release is selective and depends on the stimulus applied. In this respect AF-2 mimics, at least in part, the actions of both glucocorticoids and lipocortin-1.

Full Text

The Full Text of this article is available as a PDF (369.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angus J. A., Bobik A., Korner P. I., Stoneham M. T. Guanethidine-induced vasodilatation in the rabbit, mediated by endogenous histamine. Br J Pharmacol. 1978 Jan;62(1):7–17. doi: 10.1111/j.1476-5381.1978.tb07000.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Camussi G., Tetta C., Bussolino F., Baglioni C. Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. J Exp Med. 1990 Mar 1;171(3):913–927. doi: 10.1084/jem.171.3.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carnuccio R., Di Rosa M., Ialenti A., Iuvone T., Sautebin L. Selective inhibition by vasocortin of histamine release induced by dextran and concanavalin-A from rat peritoneal cells. Br J Pharmacol. 1989 Sep;98(1):32–34. doi: 10.1111/j.1476-5381.1989.tb16857.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cirino G., Flower R. J., Browning J. L., Sinclair L. K., Pepinsky R. B. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung. Nature. 1987 Jul 16;328(6127):270–272. doi: 10.1038/328270a0. [DOI] [PubMed] [Google Scholar]
  5. Crumpton M. J., Dedman J. R. Protein terminology tangle. Nature. 1990 May 17;345(6272):212–212. doi: 10.1038/345212a0. [DOI] [PubMed] [Google Scholar]
  6. Davidson F. F., Dennis E. A. Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2. Biochem Pharmacol. 1989 Nov 1;38(21):3645–3651. doi: 10.1016/0006-2952(89)90567-4. [DOI] [PubMed] [Google Scholar]
  7. De Nucci G., Astbury P., Read N., Salmon J. A., Moncada S. Release of eicosanoids from isolated lungs of guinea-pigs exposed to pure oxygen: effect of dexamtethasone. Eur J Pharmacol. 1986 Jul 15;126(1-2):11–20. doi: 10.1016/0014-2999(86)90732-6. [DOI] [PubMed] [Google Scholar]
  8. Di Rosa M., Flower R. J., Hirata F., Parente L., Russo-Marie F. Anti-phospholipase proteins. Prostaglandins. 1984 Oct;28(4):441–442. doi: 10.1016/0090-6980(84)90232-6. [DOI] [PubMed] [Google Scholar]
  9. Hope W. C., Patel B. J., Bolin D. R. Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities. Agents Actions. 1991 Sep;34(1-2):77–80. doi: 10.1007/BF01993243. [DOI] [PubMed] [Google Scholar]
  10. Ialenti A., Doyle P. M., Hardy G. N., Simpkin D. S., Di Rosa M. Anti-inflammatory effects of vasocortin and nonapeptide fragments of uteroglobin and lipocortin I (antiflammins). Agents Actions. 1990 Jan;29(1-2):48–49. doi: 10.1007/BF01964716. [DOI] [PubMed] [Google Scholar]
  11. Levin S. W., Butler J. D., Schumacher U. K., Wightman P. D., Mukherjee A. B. Uteroglobin inhibits phospholipase A2 activity. Life Sci. 1986 May 19;38(20):1813–1819. doi: 10.1016/0024-3205(86)90135-9. [DOI] [PubMed] [Google Scholar]
  12. Miele L., Cordella-Miele E., Facchiano A., Mukherjee A. B. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature. 1988 Oct 20;335(6192):726–730. doi: 10.1038/335726a0. [DOI] [PubMed] [Google Scholar]
  13. Märki F., Pfeilschifter J., Rink H., Wiesenberg I. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity. FEBS Lett. 1990 May 21;264(2):171–175. doi: 10.1016/0014-5793(90)80241-a. [DOI] [PubMed] [Google Scholar]
  14. Robinson C., Hoult J. R. Evidence for functionally distinct pools of phospholipase responsible for prostaglandin release from the perfused guinea-pig lung. Eur J Pharmacol. 1980 Jun 27;64(4):333–339. doi: 10.1016/0014-2999(80)90241-1. [DOI] [PubMed] [Google Scholar]
  15. SHORE P. A., BURKHALTER A., COHN V. H., Jr A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 1959 Nov;127:182–186. [PubMed] [Google Scholar]
  16. Salmon J. A. A radioimmunoassay for 6-keto-prostaglandin F1alpha. Prostaglandins. 1978 Mar;15(3):383–397. doi: 10.1016/0090-6980(78)90122-3. [DOI] [PubMed] [Google Scholar]
  17. Wallner B. P., Mattaliano R. J., Hession C., Cate R. L., Tizard R., Sinclair L. K., Foeller C., Chow E. P., Browing J. L., Ramachandran K. L. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature. 1986 Mar 6;320(6057):77–81. doi: 10.1038/320077a0. [DOI] [PubMed] [Google Scholar]
  18. van Binsbergen J., Slotboom A. J., Aarsman A. J., de Haas G. H. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity. FEBS Lett. 1989 Apr 24;247(2):293–297. doi: 10.1016/0014-5793(89)81355-9. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES